title: Incidence of hyperkalemia in high risk patients during treatment with an angiotensin converting enzyme inhibitor (Lisinopril) versus an angiotensin II receptor blocker (Losartan).
abstract: Hyperkalemia is a known side effect during treatment with Angiotensin Converting Enzyme Inhibitors (ACEIs). The purpose of this study was to compare the effect of an ACEI (Lisinopril) to an Angiotensin II Receptor Blocker (Losartan) on serum potassium (K) level in patients with known history of high normal serum K (mean = 4.8) while on treatment with ACEIs or Angiotensin II Receptor Blockers (ARBs).
authors.affiliation: USD School of Medicine, Sioux Falls, SD, USA.
authors.forename: Abdul Rahman
authors.initials: AR
authors.lastname: Zanabli
authors.forename: Angellito
authors.initials: A
authors.lastname: Yango
authors.forename: Lance
authors.initials: L
authors.lastname: Dworkin
mesh_terms: D000328:Adult; D000368:Aged; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D018592:Cross-Over Studies; D005260:Female; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D007676:Kidney Failure, Chronic / Q000150:complications; D017706:Lisinopril / Q000009:adverse effects*; D019808:Losartan / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D017706:Lisinopril; D019808:Losartan